The field of immuno-oncology has introduced novel concepts for the treatment of cancer, that harness the power of the immune system to detect and destroy malignant cells. However, dysfunctional signals in the immune system can suppress antitumor immune responses and drive the development of cancer by creating tumor-promoting inflammatory environments. Moreover, oncogenic mutations within immune cells that deregulate immune receptor signaling pathways are frequent causes of leukemias and lymphomas.
To address key questions and current concepts on tumor-immune-cell interactions, mechanisms of malignant lymphocyte transformation and ongoing efforts that exploit immune signals for cancer therapies, we will bring together world-leading immunologists and cancer researchers. Furthermore, the event will cover state-of-the-art technologies that explore immune function and metabolism in cancer at the organism, tissue, and cellular level.
Scientific Organizing Committee:
Florian Bassermann, Maike Buchner, Mathias Heikenwälder, Veit Hornung, Hendrik Poeck, Jürgen Ruland, Marc Schmidt-Supprian